Search Results - "F. Kerbauy"
-
1
Haploidentical BMT and post-transplant Cy for severe aplastic anemia: a multicenter retrospective study
Published in Bone marrow transplantation (Basingstoke) (01-05-2015)“…Patients with refractory severe aplastic anemia (SAA) who lack a matched sibling or unrelated donor need new therapeutic approaches. Hematopoietic SCT (HSCT)…”
Get full text
Journal Article -
2
Extracorporeal photopheresis combined with pentostatin in the conditioning regimen for canine hematopoietic cell transplantation does not prevent GVHD
Published in Bone marrow transplantation (Basingstoke) (01-09-2014)“…Extracorporeal photopheresis (ECP) and the purine analog pentostatin exert potent immunomodulatory effects. We evaluated the use of these treatment modalities…”
Get full text
Journal Article -
3
PP084-MON VITAMIN D DEFICIENCY IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION
Published in Clinical nutrition (Edinburgh, Scotland) (01-09-2013)Get full text
Journal Article -
4
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML
Published in Leukemia (01-06-2005)“…A total of 24 patients (median age 58; range, 27-71 years) with chronic myeloid leukemia (CML) in first chronic (CP1) (n=14), second chronic (n=4), or…”
Get full text
Journal Article -
5
ASSOCIATION OF NATURAL KILLER CELLS FUNCTIONAL SUBTYPES WITH GENETIC RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA
Published in Hematology, Transfusion and Cell Therapy (01-11-2020)Get full text
Journal Article -
6
UNRAVELLING THE HIGH INCIDENCE OF ACUTE MYELOID LEUKEMIA WITH MONOCYTIC BLAST DIFFERENTIATION IN A BRAZILIAN MULTICENTER STUDY
Published in Hematology, Transfusion and Cell Therapy (01-10-2021)“…Background: Acute myeloid leukemia with monocytic blast differentiation (AML-MC) is a rare malignancy (5-10% incidence) with a challenging diagnosis,…”
Get full text
Journal Article -
7
-
8
VASCULITE NEUTROFÍLICA CUTÂNEA COMO MANIFESTAÇÃO CLINICA EM PACIENTE COM LEUCEMIA MIELOIDE AGUDA COM MUTAÇÃO DO FLT3-TKD
Published in Hematology, Transfusion and Cell Therapy (01-10-2023)“…Objetivos: O presente estudo tem por objetivo relatar um caso de leucemia mieloide aguda associada a apresentação clínica de vasculite neutrofílica após…”
Get full text
Journal Article -
9
Extracorporeal photopheresis in addition to pentostatin in conditioning for canine hematopoietic cell transplantation: role in engraftment
Published in Bone marrow transplantation (Basingstoke) (01-10-2011)“…Extracorporeal photopheresis (ECP) and the purine analog pentostatin exert potent immunomodulatory effects, but have not been evaluated for their ability to…”
Get full text
Journal Article -
10
The effect of administration order of BU and CY on toxicity in hematopoietic SCT in humans
Published in Bone marrow transplantation (Basingstoke) (01-06-2009)Get full text
Journal Article -
11
Mycobacterium tuberculosis infection: a rare late complication after cord blood hematopoietic SCT
Published in Bone marrow transplantation (Basingstoke) (01-04-2009)Get full text
Journal Article -
12
AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LIGHT CHAIN AMYLOIDOSIS: A SINGLE CENTER REPORT
Published in Hematology, Transfusion and Cell Therapy (01-10-2024)“…Context: High dose intravenous melphalan followed by Autologous Hematopoietic Stem Cell Transplant (ASCT) has been as essential part of light chain (AL)…”
Get full text
Journal Article -
13
HCT-CI AS A PREDICTOR OF ICU ADMISSION: BRAZILIAN SINGLE-CENTER COHORT STUDY
Published in Hematology, Transfusion and Cell Therapy (01-10-2023)“…Introduction: MM is the leading indication for Autologous Stem Cell Transplantation (ASCT) globally. Although it is a safe procedure, it might be accompanied…”
Get full text
Journal Article -
14
Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole
Published in Brazilian journal of medical and biological research (01-07-2002)“…Fungal infection is one of the most important causes of morbidity and mortality in bone marrow transplant (BMT) recipients. The growing incidence of these…”
Get full text
Journal Article -
15
Importance of combined-modality therapy for primary bone lymphoma
Published in Leukemia & lymphoma (01-10-2003)“…Primary bone lymphoma (PBL) is a rare entity and comprises about 5% of all extranodal non-Hodgkin's lymphomas (NHL) and 7% of all primary bone tumors. To date…”
Get full text
Journal Article -
16
DERMATOSE NEUTROFÍLICA ASSOCIADA A AZACITIDINA
Published in Hematology, Transfusion and Cell Therapy (01-10-2024)“…Introdução: A Azacitidina, um agente hipometilante utilizado no tratamento da Síndrome Mielodisplásica (SMD) e Leucemia Mieloide Aguda (LMA), é conhecida por…”
Get full text
Journal Article -
17
DOENÇA DO ENXERTO CONTRA HOSPEDEIRO HIPERAGUDO: RELATO DE CASO
Published in Hematology, Transfusion and Cell Therapy (01-10-2024)“…Introdução: A Doença do enxerto contra hospedeiro (DECH) hiperaguda é uma complicação rara no transplante de células tronco hematopoiéticas (TCTH). É…”
Get full text
Journal Article -
18
REFRATARIEDADE PLAQUETÁRIA SECUNDÁRIA A ANTICORPO ANTI-ANTÍGENO PLAQUETÁRIO HUMANO 1A EM TRANSPLANTE DE MEDULA ÓSSEA: RELATO DE CASO
Published in Hematology, Transfusion and Cell Therapy (01-10-2024)“…Introdução: O anticorpo anti-antígeno plaquetário humano 1a (anti-HPA-1a) está classicamente associado à púrpura aloimune neonatal. Sua descrição no…”
Get full text
Journal Article -
19
DESENVOLVIMENTO DE ÍNDICE PROGNÓSTICO PARA PACIENTES ADULTOS COM LEUCEMIA LINFOBLÁSTICA AGUDA NA REALIDADE NACIONAL
Published in Hematology, Transfusion and Cell Therapy (01-10-2023)“…A Leucemia linfoblástica aguda (LLA) está associada a menor sobrevida global (SG) e livre de progressão (SLP) em adultos devido a múltiplos fatores de risco e…”
Get full text
Journal Article -
20
O VALOR DA DOENÇA RESIDUAL MENSURÁVEL POR CITOMETRIA DE FLUXO NA LEUCEMIA MIELOIDE AGUDA: DO TRATAMENTO QUIMIOTERÁPICO AO PÓS-TRANSPLANTE
Published in Hematology, Transfusion and Cell Therapy (01-10-2021)“…Introdução: A doença residual mensurável (DRM) é um marcador prognóstico independente em pacientes com LMA, auxiliando na estratificação de risco e plano…”
Get full text
Journal Article